文献速递血脂与心血管预防

长期中等强度运动不增加他汀使用者肌肉损伤标志物

Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users.
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

该研究纳入症状性他汀使用者35例、无症状性他汀使用者34例及对照31例,连续4天每日步行30、40或50公里,评估肌肉损伤标志物、肌肉表现及症状。结果显示运动后各组肌肉损伤标志物均升高,但组间升幅无差异;辅酶Q10水平组间无差异且与标志物无关。提示他汀使用及肌肉症状不加剧中等强度运动诱导的肌肉损伤。

要点

  • 连续4天中等强度步行后,他汀使用者与对照的肌肉损伤标志物升幅无差异。
  • 症状性他汀使用者基线肌肉疼痛评分更高,但运动后增加幅度与其他组相似。
  • 白细胞辅酶Q10水平组间无差异,且与肌肉损伤标志物、疲劳抵抗及症状无关。

核心结论

  • 他汀使用及他汀相关肌肉症状不加剧中等强度运动后的肌肉损伤。
  • 肌肉损伤标志物与白细胞辅酶Q10水平无关。

研究设计与样本

  • 研究纳入症状性他汀使用者35例(年龄62±7岁)、无症状性他汀使用者34例(年龄66±7岁)及对照31例(年龄66±5岁)。
  • 受试者连续4天每日步行30、40或50公里,基线与运动后评估肌肉损伤标志物、肌肉表现及报告肌肉症状。
  • 基线测量白细胞辅酶Q10水平。

主要发现

  • 所有肌肉损伤标志物基线时组间相当(P > 0.05),运动后均升高(P < 0.001),升幅组间无差异(P > 0.05)。
  • 症状性他汀使用者基线肌肉疼痛评分更高(P < 0.001),运动后所有组均相似增加(P < 0.001)。
  • 运动后症状性他汀使用者肌肉放松时间增加较对照更多(P = 0.035)。
  • 辅酶Q10水平在症状性(2.3 nmol/U;IQR:1.8-2.9 nmol/U)、无症状性(2.1 nmol/U;IQR:1.8-2.5 nmol/U)及对照(2.1 nmol/U;IQR:1.8-2.3 nmol/U)间无差异(P = 0.20)。
  • 辅酶Q10水平与肌肉损伤标志物、疲劳抵抗或报告肌肉症状无关。

临床怎么用

  • 对于有他汀相关肌肉症状的患者,中等强度长期运动不增加肌肉损伤标志物,可支持运动建议。
  • 白细胞辅酶Q10水平不宜作为他汀使用者运动相关肌肉损伤的预测指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Statin use may exacerbate exercise-induced skeletal muscle injury caused by reduced coenzyme Q10 (CoQ10) levels, which are postulated to produce mitochondrial dysfunction. OBJECTIVES: We determined the effect of prolonged moderate-intensity exercise on markers of muscle injury in statin users with and without statin-associated muscle symptoms. We also examined the association between leukocyte CoQ10 levels and muscle markers, muscle performance, and reported muscle symptoms. METHODS: Symptomatic (n = 35; age 62 ± 7 years) and asymptomatic statin users (n = 34; age 66 ± 7 years) and control subjects (n = 31; age 66 ± 5 years) walked 30, 40, or 50 km/d for 4 consecutive days. Muscle injury markers (lactate dehydrogenase, creatine kinase, myoglobin, cardiac troponin I, and N-terminal pro-brain natriuretic peptide), muscle performance, and reported muscle symptoms were assessed at baseline and after exercise. Leukocyte CoQ10 was measured at baseline. RESULTS: All muscle injury markers were comparable at baseline (P > 0.05) and increased following exercise (P < 0.001), with no differences in the magnitude of exercise-induced elevations among groups (P > 0.05). Muscle pain scores were higher at baseline in symptomatic statin users (P < 0.001) and increased similarly in all groups following exercise (P < 0.001). Muscle relaxation time increased more in symptomatic statin users than in control subjects following exercise (P = 0.035). CoQ10 levels did not differ among symptomatic (2.3 nmol/U; IQR: 1.8-2.9 nmol/U), asymptomatic statin users (2.1 nmol/U; IQR: 1.8-2.5 nmol/U), and control subjects (2.1 nmol/U; IQR: 1.8-2.3 nmol/U; P = 0.20), and did not relate to muscle injury markers, fatigue resistance, or reported muscle symptoms. CONCLUSIONS: Statin use and the presence of statin-associated muscle symptoms does not exacerbate exercise-induced muscle injury after moderate exercise. Muscle injury markers were not related to leukocyte CoQ10 levels. (Exercise-induced Muscle Damage in Statin Users; NCT05011643).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Allard NAE, Janssen L, Lagerwaard B, et al. Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users. J Am Coll Cardiol. 2023. PMID: 37019582. doi:10.1016/j.jacc.2023.01.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。